🚀总统级 #ESMO26
HARMONi-GI1 用于晚期 BTC

🟢Ivonescimab-GemCis 对比 Durva-Gemcis

✅mOS: 14.9 对比 12.1 个月; HR 0.75, 95% CI 0.61-0.92, P = 0.0031
✅mPFS: 8.4 对比 5.8 个月, HR 0.61, 95% CI 0.51-0.72, P <0.0001
✅ORR: 53.8 % 对比 32.5 % (P <0.0001)

#cancer #oncology #MedX @OncoAlert #biliary #cholangiocarcinoma #gallbladder